Cost-related Nonadherence to Medications Among Patients with Diabetes and Chronic Pain: Factors Beyond Finances

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2009 Sep 5

PMID 19729527

Citations 39

Authors

Jacob E Kurlander

Eve A Kerr

Sarah Krein

Michele Heisler

John D Piette

Affiliations

Soon will be listed here.

Abstract

Objective: In the face of financial constraints, diabetic patients may forgo prescribed medications, causing negative health effects. This study examined how cost and noncost factors are associated with patterns of cost-related nonadherence to medications (CRN).

Research Design And Methods: This was a cross-sectional survey of patients using medications for both diabetes and chronic pain (n = 245). Patients reported their income, out-of-pocket medication costs, education level, depressive symptoms, and medication-related beliefs and whether they cut back because of cost on 1) both diabetes and pain medications, 2) diabetes medications only, 3) pain medications only, or 4) neither. Multinomial logistic regression was used to model patients' adjusted odds ratios (AORs) of falling into these four possible categories.

Results: Of the patients, 9% cut back on medications for both conditions, 13% cut back on diabetes medications alone, and 9% cut back on pain medications alone. Income <20,000 USD (AOR = 5.7, P = 0.008) and monthly medication costs >50 USD (AOR = 3.9, P = 0.02) increased patients' odds of CRN for both conditions versus neither. Low-income patients also were more likely to selectively forgo pain medications (AOR = 9.1, P = 0.001) but not diabetes medications (AOR = 2.1, P = 0.12). More depressive symptoms (AOR = 1.6, P = 0.006) and negative medication-related beliefs (AOR = 1.7, P = 0.02) increased patients' odds of cutting back selectively on medications for diabetes but not pain.

Conclusions: Patients who forgo medications for both diabetes and chronic pain appear to be influenced primarily by economic pressures, whereas patients who cut back selectively on their diabetes treatments are influenced by their mood and medication beliefs. Our findings point toward more targeted strategies to assist diabetic patients who experience CRN.

Citing Articles

A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes.

Studer C, Linder M, Pazzagli L J Health Popul Nutr. 2023; 42(1):122.

PMID: 37936205 PMC: 10631092. DOI: 10.1186/s41043-023-00459-2.

The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.

Atkins N, Mukhida K Can J Pain. 2022; 6(1):142-170.

PMID: 36092247 PMC: 9450907. DOI: 10.1080/24740527.2022.2104699.

Pain-driven emergency department visits and food insecurity: a cross-sectional study linking Canadian survey and health administrative data.

Men F, Urquia M, Tarasuk V CMAJ Open. 2022; 10(1):E8-E18.

PMID: 35017172 PMC: 8758177. DOI: 10.9778/cmajo.20210056.

Validation of the Arabic Version of General Medication Adherence Scale (GMAS) in Sudanese Patients with Diabetes Mellitus.

Mahmoud M, Islam M, Ahmed M, Bashir R, Ibrahim R, Al-Nemiri S Risk Manag Healthc Policy. 2021; 14:4235-4241.

PMID: 34675717 PMC: 8518136. DOI: 10.2147/RMHP.S325184.

Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.

Gembillo G, Ingrasciotta Y, Crisafulli S, Luxi N, Siligato R, Santoro D Int J Mol Sci. 2021; 22(9).

PMID: 34062938 PMC: 8124790. DOI: 10.3390/ijms22094824.

References

Alexander G, Casalino L, Meltzer D . Physician strategies to reduce patients' out-of-pocket prescription costs. Arch Intern Med. 2005; 165(6):633-6. DOI: 10.1001/archinte.165.6.633. View

Tamblyn R, Laprise R, Hanley J, Abrahamowicz M, Scott S, Mayo N . Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001; 285(4):421-9. DOI: 10.1001/jama.285.4.421. View

Kennedy J, Morgan S . A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health. Clin Ther. 2006; 28(8):1217-1224. DOI: 10.1016/j.clinthera.2006.07.009. View

Piette J, Heisler M, Wagner T . Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004; 94(10):1782-7. PMC: 1448534. DOI: 10.2105/ajph.94.10.1782. View

Fortess E, Soumerai S, McLaughlin T, Ross-Degnan D . Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting. J Am Geriatr Soc. 2001; 49(6):793-7. DOI: 10.1046/j.1532-5415.2001.49158.x. View

Piette J, Heisler M, Horne R, Alexander G . A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2005; 62(4):846-57. DOI: 10.1016/j.socscimed.2005.06.045. View

Wilson I, Schoen C, Neuman P, Strollo M, Rogers W, Chang H . Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors. J Gen Intern Med. 2007; 22(1):6-12. PMC: 1824770. DOI: 10.1007/s11606-006-0093-0. View

Goldman D, Joyce G, Escarce J, Pace J, Solomon M, Laouri M . Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004; 291(19):2344-50. DOI: 10.1001/jama.291.19.2344. View

Tseng C, Tierney E, Gerzoff R, Dudley R, Waitzfelder B, Ackermann R . Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care. 2007; 31(2):261-6. DOI: 10.2337/dc07-1341. View

10.

Glintborg B, Hillestrom P, Olsen L, Dalhoff K, Poulsen H . Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients. J Clin Pharmacol. 2007; 47(11):1440-9. DOI: 10.1177/0091270007307243. View

11.

Bucks R, Hawkins K, Skinner T, Horn S, Seddon P, Horne R . Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs. J Pediatr Psychol. 2009; 34(8):893-902. DOI: 10.1093/jpepsy/jsn135. View

12.

Piette J, Heisler M, Wagner T . Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol. 2006; 59(7):739-46. DOI: 10.1016/j.jclinepi.2005.11.023. View

13.

Soumerai S, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams A, Gurwitz J . Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006; 166(17):1829-35. DOI: 10.1001/archinte.166.17.1829. View

14.

Steinman M, Sands L, Covinsky K . Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2002; 16(12):793-9. PMC: 1495305. View

15.

Mojtabai R, Olfson M . Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003; 22(4):220-9. DOI: 10.1377/hlthaff.22.4.220. View

16.

Hartman M, Martin A, McDonnell P, Catlin A . National health spending in 2007: slower drug spending contributes to lowest rate of overall growth since 1998. Health Aff (Millwood). 2009; 28(1):246-61. DOI: 10.1377/hlthaff.28.1.246. View

17.

Whooley M, Kiefe C, Chesney M, Markovitz J, Matthews K, Hulley S . Depressive symptoms, unemployment, and loss of income: The CARDIA Study. Arch Intern Med. 2002; 162(22):2614-20. DOI: 10.1001/archinte.162.22.2614. View

18.

Piette J, Heisler M, Wagner T . Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004; 27(2):384-91. DOI: 10.2337/diacare.27.2.384. View

19.

Briesacher B, Gurwitz J, Soumerai S . Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007; 22(6):864-71. PMC: 2219866. DOI: 10.1007/s11606-007-0180-x. View

20.

Neuman P, Strollo M, Guterman S, Rogers W, Li A, Rodday A . Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff (Millwood). 2007; 26(5):w630-43. DOI: 10.1377/hlthaff.26.5.w630. View